Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.

Schmidt DE, Heitink-Pollé KMJ, Laarhoven AG, Bruin MCA, Veldhuisen B, Nagelkerke SQ, Kuijpers TW, Porcelijn L, van der Schoot CE, Vidarsson G, de Haas M.

Blood Adv. 2019 Jul 9;3(13):2003-2012. doi: 10.1182/bloodadvances.2019000068.

2.

Identification of a novel single-nucleotide mutation in SMIM1 gene that results in low Vel antigen expression.

van der Rijst MVE, Voorn L, Veldhuisen B, Jongerius JM, van den Akker E, van der Schoot CE.

Transfusion. 2019 Oct;59(10):E8-E10. doi: 10.1111/trf.15411. Epub 2019 Jun 19. No abstract available.

PMID:
31218697
3.

Frequency and characterization of RHD variants in serologically D- Surinamese pregnant women and D- newborns.

Zonneveld R, Kanhai HHH, Javadi A, Veldhuisen B, Brand A, Zijlmans WCWR, van der Schoot CE, Schonewille H; Rhesus in Surinamese Neonates (RheSuN) Study Group.

Transfusion. 2019 Aug;59(8):2672-2677. doi: 10.1111/trf.15394. Epub 2019 Jun 10.

PMID:
31183885
4.

Associations between single nucleotide polymorphisms and erythrocyte parameters in humans: A systematic literature review.

Timmer T, Tanck MWT, Huis In 't Veld EMJ, Veldhuisen B, Daams JG, de Kort WLAM, van der Schoot CE, van den Hurk K.

Mutat Res. 2019 Jan - Mar;779:58-67. doi: 10.1016/j.mrrev.2019.01.002. Epub 2019 Feb 2. Review.

PMID:
31097152
5.

Development of a recombinant anti-Vel immunoglobulin M to identify Vel-negative donors.

van der Rijst MVE, Lissenberg-Thunnissen SN, Ligthart PC, Visser R, Jongerius JM, Voorn L, Veldhuisen B, Vidarsson G, van den Akker E, van der Schoot CE.

Transfusion. 2019 Apr;59(4):1359-1366. doi: 10.1111/trf.15147. Epub 2019 Jan 31.

PMID:
30702752
6.

Performance evaluation study of ID RHD XT, a new genotyping assay for the detection of high-prevalence RhD negative and weak D types.

Molano A, Apraiz I, España P, Azkarate M, Vesga MÁ, Rubia M, Piedrabuena M, Puente F, Veldhuisen B, van der Schoot E, Tejedor D, López M.

Vox Sang. 2018 Oct;113(7):694-700. doi: 10.1111/vox.12701. Epub 2018 Aug 19.

PMID:
30125050
7.

A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred.

van Sambeeck JHJ, de Wit PD, Luken J, Veldhuisen B, van den Hurk K, van Dongen A, Koopman MMW, van Kraaij MGJ, van der Schoot CE, Schonewille H, de Kort WLAM, Janssen MP.

Front Med (Lausanne). 2018 Jul 25;5:199. doi: 10.3389/fmed.2018.00199. eCollection 2018.

8.

RHD genotype and zygosity analysis in the Chinese Southern Han D+, D- and D variant donors using the multiplex ligation-dependent probe amplification assay.

Ji YL, Luo H, Wen JZ, Haer-Wigman L, Veldhuisen B, Wei L, Wang Z, Ligthart P, Lodén-van Straaten M, Fu YS, van der Schoot CE, Luo GP.

Vox Sang. 2017 Oct;112(7):660-670. doi: 10.1111/vox.12554. Epub 2017 Aug 18.

PMID:
28833187
9.

RhIg-prophylaxis is not influenced by FCGR2/3 polymorphisms involved in red blood cell clearance.

Stegmann TC, Veldhuisen B, Nagelkerke SQ, Winkelhorst D, Schonewille H, Verduin EP, Kuijpers TW, de Haas M, Vidarsson G, van der Schoot CE.

Blood. 2017 Feb 23;129(8):1045-1048. doi: 10.1182/blood-2016-05-716365. Epub 2017 Jan 12. No abstract available.

PMID:
28082442
10.

Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform.

López M, Apraiz I, Rubia M, Piedrabuena M, Azkarate M, Veldhuisen B, Vesga MÁ, Van Der Schoot E, Puente F, Tejedor D.

Blood Transfus. 2018 Feb;16(2):193-199. doi: 10.2450/2016.0146-16. Epub 2016 Nov 25.

11.

Validation of the multiplex ligation-dependent probe amplification assay and its application on the distribution study of the major alleles of 17 blood group systems in Chinese donors from Guangzhou.

Ji Y, Wen J, Veldhuisen B, Haer-Wigman L, Wang Z, Lodén-van Straaten M, Wei L, Luo G, Fu Y, van der Schoot CE.

Transfusion. 2017 Feb;57(2):423-432. doi: 10.1111/trf.13940. Epub 2016 Nov 27.

PMID:
27891625
12.

Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.

de Haas M, Thurik FF, van der Ploeg CP, Veldhuisen B, Hirschberg H, Soussan AA, Woortmeijer H, Abbink F, Page-Christiaens GC, Scheffer PG, Ellen van der Schoot C.

BMJ. 2016 Nov 7;355:i5789. doi: 10.1136/bmj.i5789.

13.

Identification of a novel frequent RHCE*ce308T variant allele in Chinese D- individuals, resulting in a C+c- phenotype.

Stegmann TC, Ji Y, Bijman R, Wang Z, Wen J, Wei L, Veldhuisen B, Haer-Wigman L, Lighthart P, Lodén-van Straaten M, Luo G, van der Schoot CE.

Transfusion. 2016 Sep;56(9):2314-21. doi: 10.1111/trf.13709. Epub 2016 Jun 24.

PMID:
27338008
14.

Fetal RHD genotyping after bone marrow transplantation.

Thurik FF, Page-Christiaens GC, Ait Soussan A, Ligthart PC, Cheroutre GM, Bossers B, Veldhuisen B, van der Schoot CE, de Haas M.

Transfusion. 2016 Aug;56(8):2122-6. doi: 10.1111/trf.13669. Epub 2016 May 30.

PMID:
27239725
15.

Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.

Papasavva T, Martin P, Legler TJ, Liasides M, Anastasiou G, Christofides A, Christodoulou T, Demetriou S, Kerimis P, Kontos C, Leontiades G, Papapetrou D, Patroclos T, Phylaktou M, Zottis N, Karitzie E, Pavlou E, Kountouris P, Veldhuisen B, van der Schoot E, Kleanthous M.

BMC Res Notes. 2016 Apr 1;9:198. doi: 10.1186/s13104-016-2002-x.

16.

Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women.

Stegmann TC, Veldhuisen B, Bijman R, Thurik FF, Bossers B, Cheroutre G, Jonkers R, Ligthart P, de Haas M, Haer-Wigman L, van der Schoot CE.

Br J Haematol. 2016 May;173(3):469-79. doi: 10.1111/bjh.13960. Epub 2016 Mar 27.

PMID:
27018217
17.
18.

Analysis of false-positive results of fetal RHD typing in a national screening program reveals vanishing twins as potential cause for discrepancy.

Thurik FF, Ait Soussan A, Bossers B, Woortmeijer H, Veldhuisen B, Page-Christiaens GC, de Haas M, van der Schoot CE.

Prenat Diagn. 2015 Aug;35(8):754-60. doi: 10.1002/pd.4600. Epub 2015 May 19.

PMID:
25855535
19.

Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population.

Ji Y, Veldhuisen B, Ligthart P, Haer-Wigman L, Jongerius J, Boujnan M, Ait Soussan A, Luo G, Fu Y, van der Schoot CE, de Haas M.

Transfusion. 2015 Feb;55(2):413-21. doi: 10.1111/trf.12838. Epub 2014 Aug 25.

PMID:
25156717
20.

Molecular typing of human platelet and neutrophil antigens (HPA and HNA).

Veldhuisen B, Porcelijn L, Ellen van der Schoot C, de Haas M.

Transfus Apher Sci. 2014 Apr;50(2):189-99. doi: 10.1016/j.transci.2014.02.014. Epub 2014 Mar 6. Review.

PMID:
24685245
21.

Noninvasive prenatal blood group and HPA-1a genotyping: the current European experience.

van der Schoot CE, Thurik FF, Veldhuisen B, de Haas M.

Transfusion. 2013 Nov;53(11 Suppl 2):2834-6. doi: 10.1111/trf.12411. Epub 2013 Sep 4. No abstract available.

PMID:
24004336
22.

Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy.

Haer-Wigman L, Ji Y, Lodén M, de Haas M, van der Schoot CE, Veldhuisen B.

Transfusion. 2013 Nov;53(11 Suppl 2):2899-909. doi: 10.1111/trf.12410. Epub 2013 Aug 29.

PMID:
23992446
23.

RHD and RHCE variant and zygosity genotyping via multiplex ligation-dependent probe amplification.

Haer-Wigman L, Veldhuisen B, Jonkers R, Lodén M, Madgett TE, Avent ND, de Haas M, van der Schoot CE.

Transfusion. 2013 Jul;53(7):1559-74. doi: 10.1111/j.1537-2995.2012.03919.x. Epub 2012 Oct 9.

PMID:
23043317
24.

Molecular analysis of the York antigen of the Knops blood group system.

Veldhuisen B, Ligthart PC, Vidarsson G, Roels I, Folman CC, van der Schoot CE, de Haas M.

Transfusion. 2011 Jul;51(7):1389-96. doi: 10.1111/j.1537-2995.2010.02999.x. Epub 2011 Jan 7.

PMID:
21214579
25.

Hippocampal CARP over-expression solidifies consolidation of contextual fear memories.

Schenk GJ, Vreugdenhil E, Hubens CJ, Veldhuisen B, de Kloet ER, Oitzl MS.

Physiol Behav. 2011 Mar 1;102(3-4):323-31. doi: 10.1016/j.physbeh.2010.11.024. Epub 2010 Dec 2.

PMID:
21130104
26.

Over-expression of δC-DCLK-short in mouse brain results in a more anxious behavioral phenotype.

Schenk GJ, Veldhuisen B, Wedemeier O, McGown CC, Schouten TG, Oitzl M, de Kloet ER, Vreugdenhil E.

Physiol Behav. 2010 Nov 2;101(4):541-8. doi: 10.1016/j.physbeh.2010.08.002. Epub 2010 Aug 10.

PMID:
20705078
27.

Over-expression of the DCLK gene transcript CARP decreases CA3/CA1 network excitability.

Schenk GJ, Werkman T, Wadman W, Veldhuisen B, Dijkmans TF, Blaas E, Kegel L, de Kloet ER, Vreugdenhil E.

Brain Res. 2010 Sep 17;1352:21-34. doi: 10.1016/j.brainres.2010.07.068. Epub 2010 Jul 24.

PMID:
20659433
28.

Blood group genotyping: from patient to high-throughput donor screening.

Veldhuisen B, van der Schoot CE, de Haas M.

Vox Sang. 2009 Oct;97(3):198-206. doi: 10.1111/j.1423-0410.2009.01209.x. Epub 2009 Jun 22. Review.

PMID:
19548962
29.

Will Genotyping Replace Serology in Future Routine Blood Grouping? - Opinion 5.

van der Schoot CE, Veldhuisen B, de Haas M.

Transfus Med Hemother. 2009;36(3):234-235. Epub 2009 May 28. No abstract available.

30.

Genotyping for red blood cell polymorphisms.

van der Schoot CE, de Haas M, Engelfriet CP, Reesink HW, Panzer S, Jungbauer C, Schwartz DM, Mayr WR, Castilho L, St-Louis M, Long A, Denomme G, Semple E, Fernandes B, Flegel WA, Wagner F, Doescher A, Poli F, Villa MA, Paccapelo C, Veldhuisen B, Nogués N, Muñiz-Diaz E, Daniels G, Martin P, Finning K, Reid ME.

Vox Sang. 2009 Feb;96(2):167-79. doi: 10.1111/j.1423-0410.2008.01131.x. No abstract available.

PMID:
19076336
31.

Alpha-1 antitrypsin Null mutations and severity of emphysema.

Fregonese L, Stolk J, Frants RR, Veldhuisen B.

Respir Med. 2008 Jun;102(6):876-84. doi: 10.1016/j.rmed.2008.01.009. Epub 2008 Mar 18.

32.

Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z alpha-1-antitrypsin deficiency.

Stolk J, Veldhuisen B, Annovazzi L, Zanone C, Versteeg EM, van Kuppevelt TH, Berden JH, Nieuwenhuizen W, Iadarola P, Luisetti M.

Respir Res. 2005 May 31;6:47. Erratum in: Respir Res. 2006;7(1):20. Berden, Jo H M [added].

33.

Multiple transcripts generated by the DCAMKL gene are expressed in the rat hippocampus.

Vreugdenhil E, Engels B, Middelburg R, van Koningsbruggen S, Knol J, Veldhuisen B, de Kloet ER.

Brain Res Mol Brain Res. 2001 Oct 19;94(1-2):67-74.

PMID:
11597766
34.

Location of mutations within the PKD2 gene influences clinical outcome.

Hateboer N, Veldhuisen B, Peters D, Breuning MH, San-Millán JL, Bogdanova N, Coto E, van Dijk MA, Afzal AR, Jeffery S, Saggar-Malik AK, Torra R, Dimitrakov D, Martinez I, de Castro SS, Krawczak M, Ravine D.

Kidney Int. 2000 Apr;57(4):1444-51.

35.

Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).

Veldhuisen B, Spruit L, Dauwerse HG, Breuning MH, Peters DJ.

Eur J Hum Genet. 1999 Dec;7(8):860-72.

36.

Aberrant splicing in the PKD2 gene as a cause of polycystic kidney disease.

Reynolds DM, Hayashi T, Cai Y, Veldhuisen B, Watnick TJ, Lens XM, Mochizuki T, Qian F, Maeda Y, Li L, Fossdal R, Coto E, Wu G, Breuning MH, Germino GG, Peters DJ, Somlo S.

J Am Soc Nephrol. 1999 Nov;10(11):2342-51.

37.

A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2).

Veldhuisen B, Saris JJ, de Haij S, Hayashi T, Reynolds DM, Mochizuki T, Elles R, Fossdal R, Bogdanova N, van Dijk MA, Coto E, Ravine D, Nørby S, Verellen-Dumoulin C, Breuning MH, Somlo S, Peters DJ.

Am J Hum Genet. 1997 Sep;61(3):547-55.

38.

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein.

Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJ, Somlo S.

Science. 1996 May 31;272(5266):1339-42.

PMID:
8650545
39.

Analysis of a large family with the second type of autosomal dominant polycystic kidney disease.

Veldhuisen B, Breuning MH, Wesby-van Swaay E, Boersma J, Peters DJ.

Nephrol Dial Transplant. 1996;11 Suppl 6:13-7.

PMID:
9044321
40.

Comparison of introns in a cdc2-homologous gene within a number of Plasmodium species.

Vinkenoog R, Veldhuisen B, Sperança MA, del Portillo HA, Janse C, Waters AP.

Mol Biochem Parasitol. 1995 May;71(2):233-41.

PMID:
7477105

Supplemental Content

Loading ...
Support Center